Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,453,369
-
Share change
-
-2,103,451
-
Total reported value
-
$18,046,053
-
Put/Call ratio
-
118%
-
Price per share
-
$3.31
-
Number of holders
-
58
-
Value change
-
-$7,045,445
-
Number of buys
-
22
-
Number of sells
-
46
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q3 2020
As of 30 Sep 2020,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,453,369 shares.
The largest 10 holders included
VANGUARD GROUP INC, ETF MANAGERS GROUP, LLC, Mirae Asset Global Investments Co., Ltd., Prentice Capital Management, LP, BlackRock Inc., AdvisorShares Investments LLC, JPMORGAN CHASE & CO, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP.
This page lists
58
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.